261 related articles for article (PubMed ID: 28257844)
21. miR-433 inhibits oral squamous cell carcinoma (OSCC) cell growth and metastasis by targeting HDAC6.
Wang XC; Ma Y; Meng PS; Han JL; Yu HY; Bi LJ
Oral Oncol; 2015 Jul; 51(7):674-82. PubMed ID: 25962939
[TBL] [Abstract][Full Text] [Related]
22. Down-regulation of 1D-myo-inositol 1,4,5-trisphosphate 3-kinase A protein expression in oral squamous cell carcinoma.
Kato H; Uzawa K; Onda T; Kato Y; Saito K; Nakashima D; Ogawara K; Bukawa H; Yokoe H; Tanzawa H
Int J Oncol; 2006 Apr; 28(4):873-81. PubMed ID: 16525636
[TBL] [Abstract][Full Text] [Related]
23. UBE2S elongates ubiquitin chains on APC/C substrates to promote mitotic exit.
Garnett MJ; Mansfeld J; Godwin C; Matsusaka T; Wu J; Russell P; Pines J; Venkitaraman AR
Nat Cell Biol; 2009 Nov; 11(11):1363-9. PubMed ID: 19820702
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis C Virus Downregulates Ubiquitin-Conjugating Enzyme E2S Expression To Prevent Proteasomal Degradation of NS5A, Leading to Host Cells More Sensitive to DNA Damage.
Pham HT; Nguyen TTT; Nguyen LP; Han SS; Lim YS; Hwang SB
J Virol; 2019 Jan; 93(2):. PubMed ID: 30381483
[TBL] [Abstract][Full Text] [Related]
25. Persephin: A potential key component in human oral cancer progression through the RET receptor tyrosine kinase-mitogen-activated protein kinase signaling pathway.
Baba T; Sakamoto Y; Kasamatsu A; Minakawa Y; Yokota S; Higo M; Yokoe H; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
Mol Carcinog; 2015 Aug; 54(8):608-17. PubMed ID: 24375483
[TBL] [Abstract][Full Text] [Related]
26. ANGPTL3 is a novel biomarker as it activates ERK/MAPK pathway in oral cancer.
Koyama T; Ogawara K; Kasamatsu A; Okamoto A; Kasama H; Minakawa Y; Shimada K; Yokoe H; Shiiba M; Tanzawa H; Uzawa K
Cancer Med; 2015 May; 4(5):759-69. PubMed ID: 25644496
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of T-type calcium channel Cav3.1 in oral squamous cell carcinoma: association with proliferation and anti-apoptotic activity.
Li RF; Man QW; Liu JY; Zheng YY; Gao X; Liu HM
J Mol Histol; 2021 Jun; 52(3):511-520. PubMed ID: 33394292
[TBL] [Abstract][Full Text] [Related]
28. Daxx and TCF4 interaction links to oral squamous cell carcinoma growth by promoting cell cycle progression via induction of cyclin D1 expression.
Lin GJ; Huang YS; Lin CK; Huang SH; Shih HM; Sytwu HK; Chen YW
Clin Oral Investig; 2016 Apr; 20(3):533-40. PubMed ID: 26205068
[TBL] [Abstract][Full Text] [Related]
29. High expression of EZH2 is associated with tumor proliferation and prognosis in human oral squamous cell carcinomas.
Kidani K; Osaki M; Tamura T; Yamaga K; Shomori K; Ryoke K; Ito H
Oral Oncol; 2009 Jan; 45(1):39-46. PubMed ID: 18619895
[TBL] [Abstract][Full Text] [Related]
30. UBE2S drives elongation of K11-linked ubiquitin chains by the anaphase-promoting complex.
Wu T; Merbl Y; Huo Y; Gallop JL; Tzur A; Kirschner MW
Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1355-60. PubMed ID: 20080579
[TBL] [Abstract][Full Text] [Related]
31. FKBP11 promotes cell proliferation and tumorigenesis via p53-related pathways in oral squamous cell carcinoma.
Qiu L; Liu H; Wang S; Dai XH; Shang JW; Lian XL; Wang GH; Zhang J
Biochem Biophys Res Commun; 2021 Jun; 559():183-190. PubMed ID: 33945996
[TBL] [Abstract][Full Text] [Related]
32. Tripeptidyl peptidase II in human oral squamous cell carcinoma.
Usukura K; Kasamatsu A; Okamoto A; Kouzu Y; Higo M; Koike H; Sakamoto Y; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
J Cancer Res Clin Oncol; 2013 Jan; 139(1):123-30. PubMed ID: 22986808
[TBL] [Abstract][Full Text] [Related]
33. NLRP3 promotes tumor growth and metastasis in human oral squamous cell carcinoma.
Wang H; Luo Q; Feng X; Zhang R; Li J; Chen F
BMC Cancer; 2018 May; 18(1):500. PubMed ID: 29716544
[TBL] [Abstract][Full Text] [Related]
34. Long non-coding RNA C5orf66-AS1 prevents oral squamous cell carcinoma through inhibiting cell growth and metastasis.
Lu T; Liu H; You G
Int J Mol Med; 2018 Dec; 42(6):3291-3299. PubMed ID: 30280186
[TBL] [Abstract][Full Text] [Related]
35. Critical role of deoxynucleotidyl transferase terminal interacting protein 1 in oral cancer.
Sawai Y; Kasamatsu A; Nakashima D; Fushimi K; Kasama H; Iyoda M; Kouzu Y; Shiiba M; Tanzawa H; Uzawa K
Lab Invest; 2018 Aug; 98(8):980-988. PubMed ID: 29855544
[TBL] [Abstract][Full Text] [Related]
36. Ubiquitin-conjugating enzyme 3 delays human lens epithelial cells in metaphase.
Liu Q; Shang F; Whitcomb E; Guo W; Li W; Taylor A
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1302-9. PubMed ID: 16565361
[TBL] [Abstract][Full Text] [Related]
37. Identification of a physiological E2 module for the human anaphase-promoting complex.
Williamson A; Wickliffe KE; Mellone BG; Song L; Karpen GH; Rape M
Proc Natl Acad Sci U S A; 2009 Oct; 106(43):18213-8. PubMed ID: 19822757
[TBL] [Abstract][Full Text] [Related]
38. Ubiquitin chain-elongating enzyme UBE2S activates the RING E3 ligase APC/C for substrate priming.
Martinez-Chacin RC; Bodrug T; Bolhuis DL; Kedziora KM; Bonacci T; Ordureau A; Gibbs ME; Weissmann F; Qiao R; Grant GD; Cook JG; Peters JM; Wade Harper J; Emanuele MJ; Brown NG
Nat Struct Mol Biol; 2020 Jun; 27(6):550-560. PubMed ID: 32393902
[TBL] [Abstract][Full Text] [Related]
39. UBE2S enhances the ubiquitination of p53 and exerts oncogenic activities in hepatocellular carcinoma.
Pan YH; Yang M; Liu LP; Wu DC; Li MY; Su SG
Biochem Biophys Res Commun; 2018 Sep; 503(2):895-902. PubMed ID: 29928880
[TBL] [Abstract][Full Text] [Related]
40. UBE2S promotes the proliferation and survival of human lung adenocarcinoma cells.
Liu Z; Xu L
BMB Rep; 2018 Dec; 51(12):642-647. PubMed ID: 30545437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
